DR. ALEXANDRA P IKEGUCHI M.D.
Prescription History 1962402321
Internal Medicine - Hematology in Houston, TX
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ALEXANDRA P IKEGUCHI M.D., an active Hematology specialist practicing in Houston, TX. Our medical registry currently tracks 12 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 236 documented patient claims. Among these therapy options, the most frequently utilized medication is Ondansetron Hcl, which accounts for 35 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other TX PrescribersVs. TX Avg |
|---|---|---|---|
| Ondansetron Hcl | 35 | $7.83 | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 35 Medicare prescriptions for Ondansetron Hcl, about 1.9 times the volume of the typical Texas prescriber of this medication (18). Medicare paid an average of $7.83 per fill, versus $7.06 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 590 Days of Medication total across all patients in 2023 | |||
| Anastrozole | 29 | $26.21 | ▼ Less than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 29 Medicare prescriptions for Anastrozole, about half the volume of the typical Texas prescriber of this medication (65). Medicare paid an average of $26.21 per fill, versus $24.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63 30-Day Fills standardized to 30-day supplies 1,890 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 28 | $16,242.48 | ≈ Typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 28 Medicare prescriptions for Imbruvica, about the same volume as the typical Texas prescriber of this medication (28). Medicare paid an average of $16,242.48 per fill, versus $14,715.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 784 Days of Medication total across all patients in 2023 | |||
| Prednisone | 27 | $5.68▼ below TX avg | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 27 Medicare prescriptions for Prednisone, about half the volume of the typical Texas prescriber of this medication (47). Medicare paid an average of $5.68 per fill, versus $5.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 28 30-Day Fills standardized to 30-day supplies 688 Days of Medication total across all patients in 2023 | |||
| Oxycodone Hcl | 23 | $29.94 | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2023, this provider wrote 23 Medicare prescriptions for Oxycodone Hcl, about a third of the volume of the typical Texas prescriber of this medication (57). Medicare paid an average of $29.94 per fill, versus $25.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 628 Days of Medication total across all patients in 2023 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $34.34 | ▼ Less than typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2023, this provider wrote 21 Medicare prescriptions for Hydrocodone-Acetaminophen, about 17% of the volume of the typical Texas prescriber of this medication (121). Medicare paid an average of $34.34 per fill, versus $24.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 586 Days of Medication total across all patients in 2023 | |||
| IbrancePalbociclib | 13 | $14,676.08 | ▼ Less than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 13 Medicare prescriptions for Ibrance, about half the volume of the typical Texas prescriber of this medication (25). Medicare paid an average of $14,676.08 per fill, versus $14,645.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
| Letrozole | 13 | $24.61▼ below TX avg | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 13 Medicare prescriptions for Letrozole, about a quarter of the volume of the typical Texas prescriber of this medication (57). Medicare paid an average of $24.61 per fill, versus $27.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 29 30-Day Fills standardized to 30-day supplies 860 Days of Medication total across all patients in 2023 | |||
| ScemblixAsciminib Hydrochloride | 13 | $21,924.24 | ≈ Typical |
About Scemblix: Asciminib is used to treat a certain type of cancer (chronic myeloid leukemia-CML). Show more ▾ Asciminib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 13 Medicare prescriptions for Scemblix, about the same volume as the typical Texas prescriber of this medication (13). Medicare paid an average of $21,924.24 per fill, versus $19,226.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| Hydromorphone Hcl | 12 | $17.74▼ below TX avg | ▼ Less than typical |
About Hydromorphone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Hydromorphone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine. In 2023, this provider wrote 12 Medicare prescriptions for Hydromorphone Hcl, about half the volume of the typical Texas prescriber of this medication (28). Medicare paid an average of $17.74 per fill, versus $105.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 12 30-Day Fills standardized to 30-day supplies 335 Days of Medication total across all patients in 2023 | |||
| Hydrocortisone | 11 | $28.60 | ▼ Less than typical |
About Hydrocortisone: Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. Show more ▾ This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2023, this provider wrote 11 Medicare prescriptions for Hydrocortisone, about a third of the volume of the typical Texas prescriber of this medication (29). Medicare paid an average of $28.60 per fill, versus $22.30 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 328 Days of Medication total across all patients in 2023 | |||
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $61.12 | ▼ Less than typical |
About Oxycodone-Acetaminophen: This combination medication is used to help relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2023, this provider wrote 11 Medicare prescriptions for Oxycodone-Acetaminophen, about 14% of the volume of the typical Texas prescriber of this medication (76). Medicare paid an average of $61.12 per fill, versus $30.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ALEXANDRA P IKEGUCHI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology prescribing approach at this Houston, TX practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among TX prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
